How to buy Palatin Technologies stock (PTN)

Palatin Technologies is a biotechnology business based in the US. Palatin Technologies shares (PTN) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $0.97 – an increase of 10.62% over the previous week. Palatin Technologies employs 30 staff and has a trailing 12-month revenue of around $4.5 million.

Our top picks for where to buy Palatin Technologies stock

Buy Palatin Technologies stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Palatin Technologies stock price (NYSE MKT: PTN)

Use our graph to track the performance of PTN stocks over time.

Palatin Technologies shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$0.97
52-week range	$0.68 - $5.65
50-day moving average more info button	$1.03
200-day moving average more info button	$1.52
Wall St. target price	$17.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.98

Is it a good time to buy Palatin Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Palatin Technologies price performance over time

Historical closes compared with the close of $0.9679 from 2024-12-20

1 week (2024-12-13)	10.62%
1 month (2024-11-22)	0.82%
3 months (2024-09-20)	-24.38%
6 months (2024-06-21)	-48.79%

1 year (2023-12-22)	-66.39%
2 years (2022-12-22)	-62.19%
3 years (2021-12-22)	13.5
5 years (2019-12-20)	18.9975

Palatin Technologies financials

Revenue TTM	$4.5 million
Gross profit TTM	$-18,195,369
Return on assets TTM	-131.96%
Return on equity TTM	-623.2%
Profit margin	0%
Book value	$-0.01
Market Capitalization more info button	$14.7 million

TTM: trailing 12 months

Palatin Technologies share dividends

We're not expecting Palatin Technologies to pay a dividend over the next 12 months.

Have Palatin Technologies's shares ever split?

Palatin Technologies's shares were split on a 1:25 basis on 30 August 2022 . So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Palatin Technologies shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Palatin Technologies shares which in turn could have impacted Palatin Technologies's share price.

Palatin Technologies share price volatility

Over the last 12 months, Palatin Technologies's shares have ranged in value from as little as $0.68 up to $5.65. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Palatin Technologies's is 0.94. This would suggest that Palatin Technologies's shares are less volatile than average (for this exchange).

Palatin Technologies overview

Palatin Technologies, Inc. , a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. Palatin Technologies, Inc.

Frequently asked questions

What percentage of Palatin Technologies is owned by insiders or institutions?
Currently 3.502% of Palatin Technologies shares are held by insiders and 7.883% by institutions. How many people work for Palatin Technologies?
Latest data suggests 30 work at Palatin Technologies. When does the fiscal year end for Palatin Technologies?
Palatin Technologies's fiscal year ends in June. Where is Palatin Technologies based?
Palatin Technologies's address is: Cedar Brook Corporate Center, Cranbury, NJ, United States, 08512 What is Palatin Technologies's ISIN number?
Palatin Technologies's international securities identification number is: US6960774031 What is Palatin Technologies's CUSIP number?
Palatin Technologies's Committee on Uniform Securities Identification Procedures number is: 696077304